Simkovic M - Search Results

1

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.

Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, O'Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. Among authors: simkovic m. N Engl J Med. 2023 Jan 26;388(4):319-332. doi: 10.1056/NEJMoa2211582. Epub 2022 Dec 13. N Engl J Med. 2023. PMID: 36511784 Clinical Trial.

2

[Primary testicular lymphoma].

Motyčková M, Vosáhlová V, Belada D, Šimkovič M, Žák P. Motyčková M, et al. Among authors: simkovic m. Vnitr Lek. 2017 Summer;63(6):415-422. Vnitr Lek. 2017. PMID: 28840738 Review. Czech.

3

[Haemocoagulation and renal insufficiency, haemocoagulation and type 2 diabetes mellitus].

Malý J, Simkovic M, Pecka M. Malý J, et al. Among authors: simkovic m. Vnitr Lek. 2008 May;54(5):452-6. Vnitr Lek. 2008. PMID: 18630625 Review. Czech.

4

Electron spin relaxation enhancement measurements of interspin distances in human, porcine, and Rhodobacter electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO).

Fielding AJ, Usselman RJ, Watmough N, Simkovic M, Frerman FE, Eaton GR, Eaton SS. Fielding AJ, et al. Among authors: simkovic m. J Magn Reson. 2008 Feb;190(2):222-32. doi: 10.1016/j.jmr.2007.11.002. Epub 2007 Nov 6. J Magn Reson. 2008. PMID: 18037314 Free PMC article.

5

Alternative quinone substrates and inhibitors of human electron-transfer flavoprotein-ubiquinone oxidoreductase.

Simkovic M, Frerman FE. Simkovic M, et al. Biochem J. 2004 Mar 1;378(Pt 2):633-40. doi: 10.1042/BJ20031272. Biochem J. 2004. PMID: 14640977 Free PMC article.

6

Expression of human electron transfer flavoprotein-ubiquinone oxidoreductase from a baculovirus vector: kinetic and spectral characterization of the human protein.

Simkovic M, Degala GD, Eaton SS, Frerman FE. Simkovic M, et al. Biochem J. 2002 Jun 15;364(Pt 3):659-67. doi: 10.1042/BJ20020042. Biochem J. 2002. PMID: 12049629 Free PMC article.

7

Melichar B, Laco J, Fridrichová P, Simkovič M, Papajík T, Foretová L. Melichar B, et al. Among authors: simkovic m. Acta Oncol. 2012 Jan;51(1):136-8. doi: 10.3109/0284186X.2011.594810. Epub 2011 Aug 22. Acta Oncol. 2012. PMID: 21859355 No abstract available.

8

Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia.

Smolej L, Doubek M, Panovská A, Simkovič M, Brychtová Y, Belada D, Motyčková M, Mayer J. Smolej L, et al. Among authors: simkovic m. Leuk Res. 2012 Oct;36(10):1278-82. doi: 10.1016/j.leukres.2012.07.005. Epub 2012 Jul 25. Leuk Res. 2012. PMID: 22840362

9

Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice.

Červinek L, Černá O, Čaniga M, Konířová E, Hluší A, Šimkovič M, Pospíšil Z, Čermák J, Kozák T, Mayer J, Doubek M. Červinek L, et al. Among authors: simkovic m. Int J Hematol. 2012 Nov;96(5):594-9. doi: 10.1007/s12185-012-1206-7. Epub 2012 Oct 26. Int J Hematol. 2012. PMID: 23099924 Clinical Trial.

10

The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab.

Panovská A, Smolej L, Lysák D, Brychtová Y, Šimkovič M, Motyčková M, Vodárek P, Lindtnerová M, Trbušek M, Malčíková J, Pospíšilová Š, Mayer J, Doubek M. Panovská A, et al. Among authors: simkovic m. Eur J Haematol. 2013 Jun;90(6):479-85. doi: 10.1111/ejh.12106. Epub 2013 Apr 27. Eur J Haematol. 2013. PMID: 23506191 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters